Eventide Asset Management’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-600,000
| Closed | -$26.1M | – | 172 |
|
|
2023
Q3 | $26.1M | Hold |
600,000
| – | – | 0.47% | 64 |
|
|
2023
Q2 | $21.7M | Buy |
600,000
+228,898
| +62% | +$8.27M | 0.37% | 81 |
|
|
2023
Q1 | $13.8M | Buy |
371,102
+167,502
| +82% | +$6.23M | 0.25% | 107 |
|
|
2022
Q4 | $9.23M | Hold |
203,600
| – | – | 0.18% | 111 |
|
|
2022
Q3 | $14.2M | Buy |
203,600
+90,600
| +80% | +$6.33M | 0.28% | 89 |
|
|
2022
Q2 | $7.59M | Sell |
113,000
-340,781
| -75% | -$22.9M | 0.16% | 107 |
|
|
2022
Q1 | $37.3M | Buy |
453,781
+162,155
| +56% | +$13.3M | 0.58% | 56 |
|
|
2021
Q4 | $42.8M | Buy |
291,626
+162,155
| +125% | +$23.8M | 0.55% | 62 |
|
|
2021
Q3 | $22.9M | Hold |
129,471
| – | – | 0.3% | 86 |
|
|
2021
Q2 | $20.9M | Hold |
129,471
| – | – | 0.28% | 92 |
|
|
2021
Q1 | $22.2M | Hold |
129,471
| – | – | 0.33% | 90 |
|
|
2020
Q4 | $28.4M | Sell |
129,471
-171,529
| -57% | -$37.7M | 0.44% | 70 |
|
|
2020
Q3 | $50M | Hold |
301,000
| – | – | 0.98% | 33 |
|
|
2020
Q2 | $34.4M | Hold |
301,000
| – | – | 0.75% | 47 |
|
|
2020
Q1 | $23.1M | Hold |
301,000
| – | – | 0.75% | 50 |
|
|
2019
Q4 | $38.8M | Hold |
301,000
| – | – | 1.09% | 37 |
|
|
2019
Q3 | $23.5M | Buy |
301,000
+58,000
| +24% | +$4.52M | 0.77% | 49 |
|
|
2019
Q2 | $25M | Buy |
+243,000
| New | +$25M | 0.76% | 48 |
|